|
Symbol
|
RMAFZV | DSDCBL | QQHRCH | RMAZVV | LBBRDU |
|---|---|---|---|---|---|
| Name | Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible |
|
Underlying
|
AstraZeneca / Sanofi | AstraZeneca Plc. / Novo Nordisk AS (B) / Roche AG | AstraZeneca / GlaxoSmithKline / Sanofi-Aventis | AstraZeneca Plc. / BioNTech SE / Novartis AG | AstraZeneca Plc. / BioNTech SE / Novartis AG |
|
Issuer
|
|
|
|
|
|
|
Date of maturity
|
12.01.2026 | 19.06.2026 | 30.12.2026 | 30.03.2027 | 08.04.2027 |
| Bid | - | 73.84 | - | 98.30 | 99.00 |
| Ask | - | 74.58 | - | 99.30 | 100.00 |